Calibration and preventive service NextGen sequencer
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is seeking calibration and preventive service support for a NextGen sequencer under a new requirement. This procurement falls under the Analytical Laboratory Instrument Manufacturing category (NAICS 334516) and does not utilize any small business set-asides. The solicitation is expected to be released on August 1, 2025, with an estimated award date of February 1, 2026.
The contract is valued between $250,000 and $700,000. Inquiries regarding this opportunity should be directed to the FDA's Center for Biologics Evaluation and Research (CBER) Acquisitions team at cberacquisitions@fda.hhs.gov. Additional details regarding specific performance requirements, service schedules, and technical specifications are not currently available in this forecast.
Forecast text
Calibration and preventive service NextGen sequencer
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast